Table 1.
NIL name | Population | ΔSCC (Chl10–Chl13) | |||
---|---|---|---|---|---|
Control | Treatment | ||||
Mean | P-value | Mean | P-value | ||
NIL5(+) | Cascade/Tevere | –0.4 | ns | 0.53 | * |
NIL5(–) | –0.8 | 7.13 | |||
NIL9(+) | Cascade/W156 | 1.1 | ns | 4.57 | ** |
NIL9(–) | 5.05 | 7.97 | |||
NIL10(+) | Cascade/W156 | 0.67 | ns | 1.7 | * |
NIL10(–) | 0.6 | 12.23 | |||
NIL13(+) | Cascade/Tevere | 0.15 | ns | 1.7 | * |
NIL13 (–) | 1.27 | 6.7 |
ns = non-significant at P ≤ 0.05; * = significant at P ≤ 0.05; ** = significant at P ≤ 0.01. The statistics was done using t-test. (+) indicates isolines with resistance allele from W156 or Tevere; (–) indicates isolines with susceptibility allele from Cascades.